In Conversation

China can really change healthcare globally through many different factors – investment, AI, cloud computing, big data and government policies. An environment is being created where…

Perhaps it has to do with the youth of China's biopharma industry but I find that both Chinese pharma and biotech companies behave more like US…

If you are someone like me with a bias towards action, who wants to get things done, China is the place to be!

As BioBAY has developed, the cluster effect has gotten even stronger! Today, within this small park alone, you have 69 members of China’s Thousand Talents Plan…

Many other MNCs have been recruiting more medical reps to increase their coverage, particularly in lower-tier areas. Instead of doing this, we focused on generating and…

While NHSc talks about consumer focus instead of patient focus, at the end of the day, everyone is a consumer

As a country rises to the position of second-largest global pharma market, I believe it becomes responsible to not only benefit from other countries’ innovations but…

With money, talent and policy coming together to foster this positive economic development, the environment is excellent [in China] for companies in general, both multinational and…

When people talk about R&D, it conjures up the common image of drug breakthroughs miraculously emerging from laboratories. However, so much of the heavy lifting comes…

In the longer term, China will become a major player in the global pharma industry and that is good for both Chinese people and people globally.

Recent reforms have made it clear that oncology is a national priority for the Chinese government